Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients

• Main Authors: Karina Karina (Author), Iis Rosliana (Author), Imam Rosadi (Author), Siti Sobariah (Author), Louis Martin Christoffel (Author), Rita Novariani (Author), Siti Rosidah (Author), Novy Fatkhurohman (Author), Yuli Hertati (Author), Nurlaela Puspitaningrum (Author), Wismo Reja Subroto (Author), Irsyah Afini (Author), Difky Ernanda (Author)
• 格式: 图书
• 出版: Hindawi Limited, 2021-01-01T00:00:00Z.
• 主题: article
• 在线阅读: Connect to this object online.

Background. The outbreak of Coronavirus Disease 2019 (COVID-19) has been increasing rapidly. This disease causes an increase in proinflammatory cytokine production that leads to cytokine storm or cytokine release syndrome (CRS). Autologous activated platelet-rich plasma (aaPRP) contains various type...